Janux Therapeutics (JANX.US) was first covered by Scotiabank, giving it the same rating as the market, with a target price of $47.00.
Janux Therapeutics(JANX.US)获Scotiabank首次覆盖，给予与大盘持平评级, 目标价47.00美元。
Janux Therapeutics (JANX.US) was first covered by Scotiabank, giving it the same rating as the market, with a target price of $47.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.